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UNIT 3.4Synthesis of Oligodeoxyribo- and
Oligoribonucleotides According to the
H-Phosphonate Method
BASIC
PROTOCOLThis protocol outlines a general procedure for the preparation of oligodeoxyribo- and olig-
oribonucleotides usingH-phosphonatemonomers. It is followedbyan in-depthdiscussion
of the advantages of theH-phosphonate approach as well as its underlying chemistry (see
Commentary). The preparation of the H-phosphonate monomers can be achieved by a
variety of methods; these are presented in UNIT 2.6.
Oligonucleotide synthesis employing H-phosphonates is considerably simpler than syn-
thesis using the phosphotriester or phosphoramidite procedures. The elongation cycle
includes only two chemical steps: deprotection of the terminal 5′-OH function of the
support-bound oligonucleotide, and coupling of the 5′-OH with a nucleoside 3′-H-
phosphonate in the presence of a condensing agent (Fig. 3.4.1). After completion of
the desired number of elongation cycles (i.e., assembly of the oligomeric chain), a single
oxidation cycle is performed to convert the internucleoside H-phosphonate functions to
phosphodiesters (or some analog, such as phosphorothioates). Finally, the linkage be-
tween the oligomer and the support is cleaved under ammonolytic conditions, which
is also the final deprotection step for oligodeoxyribonucleotide and oligoribonucleotide
synthesis with 2′-O-2-chlorobenzoyl groups (also see UNIT 2.6). Purification by standard
methods is then carried out to isolate the oligonucleotides.
The synthetic protocol described below was optimized for oligoribonucleotide synthesis
with 5′-O-MMTr and 2′-O-TBDMS protection on a modified Gene Assembler (Pharma-
cia) with a polystyrene support. It also gives good results with 2′-O-alkyl RNA and fairly
good results for oligodeoxyribonucleotide synthesis. Controlled-pore glass (CPG) can be
used, but has proven to be less reliable in the authors’ experience.
The efficiency of each elongation step in solid-phase oligonucleotide synthesis is usually
high, but technical aspects of the procedure may have to be adjusted for each particu-
lar machine. The most important of these are probably (1) the time of H-phosphonate
preactivation before it reaches the solid support, (2) the concentration of the condensing
agent, and (3) the proportion of pyridine in the solvent mixture. Some recently intro-
duced condensing agents—e.g., bis(pentafluorophenyl) carbonate (Efimov et al., 1993)
and carbonium- and phosphonium-based condensing agents (Wada et al., 1997)—seem
to make the condensation less sensitive to these factors.
The reaction conditions for the removal of the acid-labile 5′-O-MMTr or 5′-O-DMTr
groups (usually 1% to 2%of various haloacetic acids in an anhydrous chlorinated solvent)
have been shownnot to affect the integrity of theH-phosphonate linkageswithin a relevant
time (Stawinski et al., 1988). The most important factors affecting the condensation and
oxidation steps are discussed later (see Commentary).
Materials
1,2-Dichloroethane (DCE; BDH) over 4-Å molecular sieves
Trifluoroacetic acid (TFA; Fluka)
Dichloroacetic acid (DCA; Lancaster, 99%), distilled
Acetonitrile (MeCN; Lab-Scan) over 3-Å molecular sieves
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Figure 3.4.1 Condensation of protected nucleoside H-phosphonate monoester with a nucleoside and conversion to the
dinucleoside phosphate or backbone-modified analog.
Pyridine (Py; Lab-Scan, Anhydroscan) over 4-Å molecular sieves
Protected nucleoside 3′-H-phosphonate building blocks (triethylammonium salts;
see Commentary and UNIT 2.6)
Pivaloyl chloride (Pv-Cl; Acros Organics, 99%), freshly distilled
Polystyrene support (PE Applied Biosystems) loaded at 20 to 30 µmol/g with a
5′-O-(4,4′-dimethoxytrityl) (DMTr)– or 5′-O-(4-monomethoxytrityl)
(MMTr)–protected nucleoside succinate (or equivalent nucleoside-loaded solid
support)
I2
Diethyl ether
Concentrated (28% to 32%) aqueous ammonium hydroxide (NH4OH) or 3:1 (v/v)
concentrated NH4OH/ethanol
Triethylamine trihydrofluoride (for RNA synthesis with 2′-O-TBDMS protection)
n-Butanol
20 mM sodium acetate buffer, pH 6.5, containing 30% and 10% MeCN
LiClO4
0.1 M triethylammonium acetate (TEAA) buffer, pH 6.5
Automated oligonucleotide synthesizer (Gene Assembler, Pharmacia)
5-mL syringes with Luer lock
1.5-mL cryovials with screw caps
Glass sintered funnel of coarse porosity
Speedvac evaporator and a vacuum pump
C18 cartridge (Waters Sep-Pac)
Syringe filters (Millex-GV13 filter, 0.22-µm, 13 mm) and disposable syringes
4 × 250–mm Dionex NucleoPac PA-100 column
Lyophilizer
4.6 × 150–mm Supelcosil LC-18 (3 µm) column
Additional reagents and equipment for automated oligonucleotide synthesis
(APPENDIX 3C) and purification by ion-exchange and reversed-phase HPLC
(UNIT 10.5)
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Table 3.4.1 Stepwise Oligonucleotide Synthesis Program
Step Reagenta Time (min) Flow rate(mL/min)
Wash DCE 2.0 2
Detritylation For 5′-O-MMTr-RNA or 2′-O-alkyl-RNA:
1% TFA/DCE 1.0 2
For 5′-O-DMTr-DNA:
3.5% DCA/DCE 2.0 2
For mixed 5′-O-MMTr-RNA/2′-O-alkyl-RNA
and DNA:
3.5% DCA/DCE 2.5 2
Wash DCE 2.0 2
MeCN 1.0 2
3:1 (v/v) MeCN/Py 1.0 2
Coupling 50 mM phosphonate 0.1 1
225 mM Pv-Cl 0.1 1
50 mM phosphonate 0.1 1
225 mM Pv-Cl 0.1 1
50 mM phosphonate 0.1 1
Pump forward 0.4 1
Pump reverse 1.0 0.5
Wash 3:1 (v/v) MeCN/Py 1.0 2
MeCN 1.0 2
Total time per cycle 10.9–12.4
aAbbrevations: DCA, dichloroacetic acid; DCE, 1,2-dichloroethane; DMTr, 4,4′-dimethoxytrityl; MeCN, acetonitrile;
MMTr, 4-methoxytrityl; Pv-Cl, pivaloyl chloride; Py, pyridine; TFA, trifluoroacetic acid.
Prepare reagents
1. Charge the synthesizer with solvents and detritylation solution needed for the steps
shown in Table 3.4.1.
These can usually be kept on the synthesizer until they are consumed.
2. Dissolve the protected nucleoside 3′-H-phosphonates (triethylammonium salts) in
pyridine and evaporate the solvent (two times) under reduced pressure in a rotary
evaporator. Use 15 µmol/coupling plus 15 µmol extra for margins and priming of
solutions.
3. Dissolve the residue in 3:1 (v/v) MeCN/pyridine to a concentration of 50 mM and
transfer to appropriate vessels for attachment to the synthesizer.
4. Prepare a solution of 225 mM pivaloyl chloride in 3:1 (v/v) MeCN/pyridine directly
in the vessel that will be used for synthesis. Prepare 0.2 mL/coupling plus 1 to 2 mL
extra for margins. Attach the vessel to the synthesizer.
5. Prime the solutions and connect a column/cartridge filled with 0.2 to 1 µmol
nucleoside-loaded support.
6. Immediately before the final oxidation step, prepare an iodine solution by dissolving
0.4 g I2 in 20 mL of 98:2 (v/v) pyridine/water.
The solution should be prepared no more than 30 min before use.
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Table 3.4.2 Final Oxidation Program
Step Reagenta Time (min) Flow rate (mL/min)
Wash DCE 2 2
Detritylation 1% TFA/DCE 1 2
Wash DCE 2 2
MeCN 1 2
Oxidation 2% I2 in 98:2 (v/v) Py/H2O 30 0.5
Wash MeCN 10 2
Total time 46
aAbbrevations: DCE, 1,2-dichloroethane; MeCN, acetonitrile; Py, pyridine; TFA, trifluoroacetic acid.
Synthesize oligonucleotide
7. Perform automated oligonucleotide synthesis (APPENDIX 3C) using the synthesis cycle
shown in Table 3.4.1, with a final oxidation step as shown in Table 3.4.2. In the
coupling step, program the synthesis so that theH-phosphonate and pivaloyl chloride
are taken up in alternating 100-µL portions.
The volume of the tubing between the valve and the column (including the pump hose of
the peristaltic pump, through which the reagents flow) is 0.4 mL, which means that the
front of the condensation mixture reaches the column when the last segment is taken up
from the reagent bottles. The segments are then passed through the column (0.4 min at
1 mL/min), and then the flow is lowered and the direction reversed (1 min at 0.5 mL/min),
giving a total condensation cycle time of 1.9 min, with an effective condensation time of
∼1.5 min. The effective time of preactivation for the nucleoside H-phosphonate when it
first reaches the column is ∼0.3 min, for a total of 1.8 min at the end of condensation.
Purify oligonucleotide
8. Remove the cartridge/column from the synthesizer andwash the supportwith∼10mL
diethyl ether using a 5-mL syringe with a Luer fitting.
9. Air dry the support using the above 5-mL syringe with a Luer fitting by pushing air
through the column a few times.
10. Remove the support from the cartridge and transfer it to a 1.5-mL cryovial (with
screw cap).
11. Carry out ammonolysis by adding 3:1 (v/v) concentrated NH4OH/ethanol (∼1 mL
for up to a 1-µmol scale synthesis) and incubating 8 to 16 hr at 20◦ to 25◦C (8-hr
incubations for sequences up to 25-mers; 16-hr incubations for longer sequences,
e.g., 50- to 60-mers).
The above conditions are for RNA oligomers with N2-phenoxyacetyl guanosine protec-
tion, N6-butyryl adenosine protection, and N4-propionyl cytidine protection, which are
recommended to avoid cleavage of TBDMS groups (and subsequent cleavage of RNA)
upon ammonolysis at elevated temperatures (Stawinski et al., 1988), which is required
for more stable base protection. Other reagents and conditions may be needed for other
protecting groups. For DNA or for 2′-O-alkyl-RNA, concentrated NH4OH should be used
alone for ∼20 hr at 55◦ to 60◦C.
12. Filter off the support using a glass sintered funnel of medium porosity.
13. Wash support with 1 mL of 3:1 (v/v) concentrated NH4OH/ethanol (or concentrated
NH4OH alone) and combine the filtrates.
14. Concentrate the oligonucleotide using a Speedvac evaporator and a vacuum pump.
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15. For RNA synthesis with 2′-O-TBDMS protection, perform deprotection step with
triethylamine trihydrofluoride (Westman and Stro¨mberg, 1994) using the following
steps:
a. Dissolve the residue in 0.3 mL neat triethylamine trihydrofluoride and incubate
14 to 16 hr at room temperature.
b. Add 30 µL water and 1 mL n-butanol, and incubate 1 hr at –20◦C.
c. Centrifuge and remove the liquid supernatant. Dissolve the pellet in HPLC
buffer (see step 16).
16. Purify by ion-exchange and reversed-phase HPLC (UNIT 10.5).
a. Dissolve the deprotected oligoribonucleotides in 0.5 mL of 20 mM sodium
acetate buffer, pH 6.5, containing 30% MeCN and filter through a disposable
C18 cartridge.
b. Wash the cartridgewith 1mLof buffer, then combine fractions and filter through
a disposable syringe attached to a 0.22-µm filter before HPLC purification.
c. Purify by anion-exchange HPLC on a 4 × 250–mm Dionex NucleoPac PA-100
column using a linear gradient of LiClO4 in 20 mM sodium acetate buffer,
pH 6.5, containing 10% MeCN at a flow rate of 1 mL/min. For analysis, inject
0.2 OD260 units; for purification, inject 15 to 30 OD260 units of crude oligori-
bonucleotides.
d. Lyophilize the collected fractions, dissolve in 1mL of 0.1M triethylammonium
acetate (TEAA) buffer, pH 6.5, and filter through a disposable syringe attached
to a 0.22-µm filter.
e. Further purify by reversed-phase HPLC on a 4.6 × 150–mm Supelcosil LC-18
column using a linear gradient of MeCN in 0.1 M TEAA buffer, pH 6.5, at a
flow rate of 1 mL/min.
f. Collect the fractions containing the product, lyophilize, dissolve in 1 mL water,
and lyophilize again.
COMMENTARY
Background Information
General information and synthetic strategies
Although the most common method to-
day for synthesis of oligonucleotides and
their analogs is the phosphoramidite ap-
proach (Beaucage and Iyer, 1993, see also
UNIT 3.3), the newer H-phosphonate method-
ology can often be a preferred alternative
(Garegg et al., 1985, 1986a,b,c; Froehler and
Matteucci, 1986; Froehler et al., 1986). The
use of H-phosphonates in nucleotide synthe-
sis was pioneered by Sir Todd’s group in
Cambridge, UK, who in 1952 demonstrated
the formation of H-phosphonate diesters in a
condensation reaction of H-phosphonate mo-
noesterswith a protected nucleoside, promoted
by diphenyl phosphorochloridate (Corby et al.,
1952; Hall et al., 1957). This chemical prin-
ciple was, however, not explored further; it
was rediscovered three decades later (Garegg
et al., 1985, 1986c) and explored for oligonu-
cleotide synthesis (Froehler and Matteucci,
1986; Froehler et al., 1986; Garegg et al.,
1986a,b,c, 1987a).
The method consists of condensing a pro-
tected nucleoside H-phosphonate monoester
(UNIT 2.6) with a nucleoside in the presence
of a coupling agent to produce the corre-
sponding dinucleoside H-phosphonate diester.
This, under various experimental conditions,
can be converted to the dinucleoside phos-
phate or to a variety of backbone-modified
analogs, e.g., phosphorothioates, phosphor-
amidates, etc. (Fig. 3.4.1).
The condensation step of the elongation cy-
cles (i.e., the formation of an internucleoside
H-phosphonate linkage between a nucleoside
3′-H-phosphonate monoester and the support-
bound 5′-hydroxylic component) is usually
carried out in pyridine-acetonitrile mixtures.
Out of the various condensing agents initially
tested, pivaloyl chloride (Pv-Cl) gave the best
results in automated solid-support synthesis
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of oligonucleotides, and it is still the most
frequently used reagent. The reaction in pyri-
dine or acetonitrile-pyridine mixtures using 2
to 5 equiv of Pv-Cl is usually fast and goes to
completion in <1 min. Nowadays, an array of
other condensing agents (see below) is avail-
able; these reagents can, in some instances, be
superior to Pv-Cl.
The H-phosphonate methodology became
commercially available (for use in auto-
mated synthesizers from Applied Biosystems
and Biosearch) soon after the initial reports
on oligonucleotide synthesis using this ap-
proach were published. The research group
at Applied Biosystems also introduced 1-
adamantanecarbonyl chloride as an alterna-
tive to Pv-Cl (Andrus et al., 1988). Although
a capping step during oligonucleotide syn-
thesis via H-phosphonate intermediates ini-
tially seemed to be superfluous, its incorpo-
ration into the synthetic protocol was shown
to potentially improve the overall perfor-
mance of the method. The procedure sim-
ply consists of an additional condensation
step using isopropylH-phosphonate after each
nucleoside H-phosphonate coupling (Andrus
et al., 1988). The use of 2-cyanoethyl H-
phosphonate for capping was also reported,
although this reagent has the disadvantage
of being less accessible. The capping proce-
dure routinely used in the phosphoramidite
approach (acylation with acetic anhydride in
the presence of nucleophilic catalysts more
powerful than pyridine) is not compatible with
H-phosphonate chemistry, owing to the occur-
rence of P-acylation (see below).
Since the introduction of the H-phos-
phonate methodology for synthesis of
oligonucleotides, a number of improvements
have been introduced. These involve new
condensing agents and new reaction condi-
tions. Oligodeoxynucleotide synthesis via
H-phosphonates has been scaled up to 10
to 14 µmol using only a few equivalents
of monomeric building blocks relative to a
support-bound oligomer per condensation
(Gaffney and Jones, 1988). The H-phos-
phonate approach was used in a cartridge-
based procedure for simultaneous synthesis
of multiple oligodeoxynucleotides (Seliger
and Ro¨sch, 1990). The H-phosphonate
methodology has been used in the synthesis of
a number of different oligonucleotide analogs,
for example, phosphoramidates (Froehler,
1986) and phosphorothioates (Agrawal and
Tang, 1990; Stein et al., 1990), including those
with all-Rp-linkages (Almer et al., 1996). It
has also been used in the synthesis of oligonu-
cleotides bearing modified heterocyclic bases
(Ramzaeva et al., 1997; Seela and Wei,
1997). One particularly interesting feature of
oligonucleotide synthesis when using the H-
phosphonate methodology is that it can be per-
formed without protection of the nucleobases
(Kung and Jones, 1992; Wada et al., 1997;
UNIT 3.10).
RNA synthesis is perhaps where the
advantages of the H-phosphonate approach
are most apparent. In the first report, the
t-butyldimethylsilyl (TBDMS) group was
used for protection of the 2′-OH and the
protocol was similar to that described for
DNA synthesis (Garegg et al., 1986a,b). A
number of subsequent reports have differed in
the choice of 2′-OH protection (see UNITS 2.2
and 3.5). These include the use of photolabile
groups (e.g., o-nitrobenzyl; Tanaka et al.,
1987), acid-sensitive groups (such as 1-(2-
chloro-4-methylphenyl)-4-methoxypiperidin-
4-yl; Ctmp; Sakatsume et al., 1989), and
base-labile benzoyl derivatives (Rozners et al.,
1988, 1990, 1992).
The H-phosphonate approach seems to be
even more suited for RNA than for DNA
synthesis. Potential problems such as dou-
ble activation (i.e., the bis-acyl phosphite
formation) and P-acylation are significantly
suppressed when using ribonucleoside H-
phosphonates (Stawinski et al., 1991b). The
condensation reaction is virtually as fast as for
DNA synthesis and at least as efficient, even
with bulky 2′-O-protection. Synthesis of olig-
oribonucleotides of up to 50 to 60 nucleotide
residues in length is readily achieved (Agrawal
and Tang, 1990; Rozners et al., 1998), and the
deprotection steps have been adjusted to more
base-labile N-protection that gives better per-
formance (Rozners et al., 1998).
The most common choice for 2′-OH pro-
tection in oligoribonucleotide synthesis is the
TBDMS group (see UNIT 3.5). Studies on the
stability of this group under the reaction con-
ditions used for removal of N-acyl groups
have been carried out (Stawinski et al., 1988;
Wu and Ogilvie, 1990). A conclusion (rele-
vant not only to the H-phosphonate approach)
was that synthesis of longer RNA oligonu-
cleotides with 2′-O-TBDMS protection would
benefit from the use of more labile N-acyl-
protecting groups for the heterocyclic base
moieties. These were later duly introduced
to the synthesis of oligoribonucleotides, both
by the phosphoramidite approach (Wu and
Ogilvie, 1988; Chaix et al., 1989) and the
H-phosphonate method (Westman et al. 1993,
1994; Rozners et al., 1998).
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Although Pv-Cl (Froehler et al., 1986;
Garegg et al., 1986a) and perhaps adamantane
carbonyl chloride (Andrus et al., 1988) are the
most popular condensing agents used in solid-
phase synthesis of oligonucleotides via the
H-phosphonate approach, several others that
may be considered for different applications
have also been evaluated. These include vari-
ous pivalic (Stro¨mberg andStawinski, 1987) or
other carboxylic acid derivatives (Ja¨ger et al.,
1987), diphenyl phosphorochloridate (Hall
et al., 1957; Garegg et al., 1985), 2-chloro-
5,5-dimethyl-2-oxo-1,3,2-dioxaphosphinane
(Stro¨mberg and Stawinski, 1987), bis(2-
oxo-3-oxazolidinyl)phosphinic chloride
(Stro¨mberg and Stawinski, 1987), various
dialkyl phosphorochloridates (Stro¨mberg
and Stawinski, 1987; Stawinski et al., 1988),
arene sulfonic acid derivatives (Garegg et al.,
1985; Ja¨ger et al., 1987; Dan’kov et al.,
1988), 1,3-dimethyl-2-chloro-imidazolium
chloride (Sakatsume et al., 1989, 1990),
bis(pentafluorophenyl)carbonate (Efimov
et al., 1993), and a number of carbonium and
phosphonium derivatives (Wada et al., 1997).
Parameters of the underlying chemistry
Activation of H-phosphonate monoesters
The formation of an internucleoside link-
ageby theH-phosphonate approach, using acyl
chlorides, proceeds via a mixed phosphono-
carboxylic anhydride that reacts with the
nucleosidic component to produce an H-
phosphonate diester (Garegg et al., 1987c;
Fig. 3.4.2). The order inwhich the reactants are
added in solution synthesis with near equimo-
lar amounts of phosphonate and nucleoside
was found to be important for the efficiency
of H-phosphonate diester formation (Garegg
et al., 1985, 1986c). The coupling reaction
is virtually quantitative when the condensing
Figure 3.4.2 Activation of H-phosphonate monoesters. R1 = protected nucleoside-3′-yl; R2 =
protected nucleoside-5′-yl.
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agent is added to a solution containing both
the alcohol and the H-phosphonate monoester.
If, on the other hand, the H-phosphonate is
preactivated with a condensing agent before
the addition of an alcohol, the reaction is
considerably less efficient. This phenomenon
was investigated and traced back to the fur-
ther activation of the initially formed interme-
diates in the absence of an alcohol (Garegg
et al., 1987c,d,e). Irrespective of the con-
densing agent used, tricoordinated phosphite
derivatives were formed; upon reaction with
an alcohol, these species (the chemical nature
of which depends on the coupling agent used)
always gave various unwanted products in ad-
dition to the H-phosphonate diesters.
Preactivation of H-phosphonate mono-
esters with acyl chlorides produces bis-acyl
phosphites (Garegg et al., 1987c). The con-
sequence of such preactivation is that, in so-
lution synthesis with near equimolar amounts
of H-phosphonate and alcohol, formation of
phosphite triesters is unavoidable (at least to
some extent). It is quite clear that such species
must also be formed to some extent when the
condensing agent and H-phosphonate are
mixed before entering the column in a syn-
thesizer. No side products that could arise
from this species have so far been detected in
solid-phase synthesis products, but it has been
shown that too long of a preactivation substan-
tially slows down the coupling reaction, and
the competing reaction of alcoholic functions
with the condensing agent becomes more pro-
nounced (Gaffney and Jones, 1988). It has also
been shown that even if condensation with nu-
cleoside bis-acyl phosphites gave the correct
product on a solid support, the reaction of a
bis-acyl phosphite with a nucleoside is sub-
stantially slower than that of the correspond-
ing H-phosphonate which is postulated to pro-
ceed via the mixed phosphono-carboxylic an-
hydride (shown in Fig. 3.4.2; Garegg et al.,
1987c; Efimov and Dubey, 1990).
Because an excess of H-phosphonate to al-
cohol is normally used in solid-phase syn-
thesis, some formation of bis-acyl phosphite
is tolerable. It is clear that the preactivation
time should be minimized so that the mix-
ture reaching the column has the highest ratio
of mixed phosphono-carboxylic anhydride to
bis-acyl phosphite as possible. Otherwise, the
oligonucleotide synthesis will lose in effi-
ciency. A preactivation time that is too long
can probably not be compensated to the full
extent by longer condensation time, because
competing reactions become more prominent.
Apart fromminimizing preactivation time, it is
also possible to reduce or change the amount
of condensing agent (which is usually used in
excess) and control the reaction by varying sol-
vent composition (see below). It is convenient
to use enough condensing agent to achieve
conditions that are not too moisture sensitive;
but over a certain level, additional excess of
acyl chloride increases the level of side reac-
tions that may lower the coupling efficiency
and overall yield.
Particularly noteworthy was the observa-
tion that H-phosphonate monoesters when ac-
tivated in the absence of a base (like pyridine)
produce only monoactivated species (Garegg
et al., 1987c). Efimov and co-workers found
that replacing pyridine by the slightly weaker
base quinoline is sufficient to suppress the
formation of bis-acyl phosphite and keep its
amount <5% to 10% within the period of
time necessary for a condensation (Efimov and
Dubey, 1990; Efimov et al., 1990). This novel
solvent mixture (acetonitrile-quinoline, 4:1
v/v)wasused in the synthesis of oligodeoxynu-
cleotides up to 39 units in length (Efimov and
Dubey, 1990). Although the replacement of
pyridine by quinoline in oligonucleotide syn-
thesis via the H-phosphonate approach offers
some advantages, the rate of condensation is
usually lower and quinoline gives some side
reactions with activated H-phosphonate mo-
noesters (Stawinski et al., 1991a). The influ-
ence of base strength on preactivation of ri-
bonucleoside H-phosphonates was examined,
and substituted pyridines that were less ba-
sic than pyridine itself were found to suppress
formation of tricoordinated species (Stawinski
et al., 1991b). With these less basic pyri-
dine derivatives, the side reactions observed
with quinoline could not be detected. Steric
factors are also likely to be important for
double activation, because, for example, the
formation of tricoordinated species is slower
for 2′-O-TBDMS-protected ribonucleoside
H-phosphonates than for the corresponding 2′-
deoxyribo derivatives.
Recently, bis(pentafluorophenyl) carbonate
(PFPC) was advocated as a condensing agent
forH-phosphonate diesters formation (Efimov
et al., 1993). The reagent may be as reactive
as Pv-Cl in promoting condensations and com-
pares favorably with Pv-Cl in regard to its re-
activity toward heterocyclic bases and the 5′-
hydroxyl function of a nucleosidic component
(Efimov et al., 1993). Although the reagent
produces double-activated species from H-
phosphonate monoesters, these are as reactive
as the initially formed monoactivated interme-
diate. Truncated sequences are claimed to be
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significantly reduced compared to the protocol
that uses Pv-Cl as a condensing agent. The util-
ity of the reagent was demonstrated in the syn-
thesis of several oligodeoxyribonucleotides
(chain length 22 to 40) and oligonucleotide-
phospholipid conjugates (Efimov et al., 1993).
Competing O-acylation
Direct reaction of a condensing agent with
hydroxylic functions in competition with the
desired coupling reaction is another potential
source of inefficiency in oligonucleotide syn-
thesis. The suggestion that capping is impor-
tant when using the H-phosphonate approach
for oligonucleotide synthesis points to a rather
low extent of acylation during the condensa-
tion step (Andrus et al., 1988; Gaffney and
Jones, 1988). Self-capping by the acyl chlo-
rides used for condensation was estimated to
account for only ∼10% to 50% of nonphos-
phonylated hydroxyls (Gaffney and Jones,
1988), which represents 0.1% to 0.5% of an
average coupling yield of 99%. When a four-
fold excess of H-phosphonate to nucleoside
and 5 equiv Pv-Cl were reacted for 1.5 min,
however, the total amount of 5′-O-acylation
was∼0.8%(Gaffney and Jones, 1988). The ex-
tent ofO-acylationdependsheavily on reaction
conditions, such as ratios and concentrations
of reagents, and is likely to be substantially
lower when a larger excess of H-phosphonate
is used in conjunction with fewer equivalents
of Pv-Cl.
The authors assert that the most impor-
tant reason for the occurrence of competing
5′-O-acylation in machine-assisted synthesis
is that the condensation is slowed down ow-
ing to formation of bis-acyl phosphites (see
above).Acylationof 5′-OHfunctions has never
been observed when the condensation reaction
is carried out in solution without preactiva-
tion. Minimizing formation of the less reac-
tive tricoordinated species (frompreactivation)
should result in higher coupling efficiency. Us-
ing fewer equivalents of condensing agent rel-
ative to H-phosphonate monoester is likely to
be the most efficient way to decrease 5′-O-
acylation, because it will affect the rate of both
O-acylation and bis-acyl phosphite formation.
Changes in solvent composition may also be
beneficial (e.g., less pyridine).
P-acylation
Another side reaction that potentially can
occur when using acyl chlorides as condens-
ing agents in the H-phosphonate approach
to oligonucleotide synthesis is the formation
of acylphosphonates (Fig. 3.4.3). When the
synthesis of an H-phosphonate diester is car-
ried out with all reactants in solution under
standard conditions (approximately equimo-
lar amounts ofH-phosphonate and nucleosidic
components together with 2 to 3 equiv of cou-
pling agent), the reaction can be quenched
long before anyP-acylation can be detected. In
solid-support oligonucleotide synthesis, how-
ever, because of iterative condensation steps,
reaction of H-phosphonate functions with the
condensing agent could become a problem.
Acylphosphonate formation was not detected
when H-phosphonate diesters were exposed
to 3 to 5 equiv of Pv-Cl in pyridine for
30 min (Regberg et al., 1988). In a study of
P-acylation, however, a slow conversion of
a di(deoxyribonucleoside) H-phosphonate to
the corresponding pivaloylphosphonate went
Figure 3.4.3 P-acylation side reaction.
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to completion in the presence of 5 equiv of Pv-
Cl in pyridine-acetonitrile after 15 hr at 20◦C
(Kuyl-Yeheskiely et al., 1986).
The P-acylation during a condensation re-
action should in principle be less pronounced,
owing to the inhibitory effect of pyridinium
ions that are formed (Stro¨mberg, 1987). In
a condensation mixture containing 5 equiv
of Pv-Cl (in pyridine-acetonitrile 1:1 v/v),
only ∼15% of the produced H-phosphonate
diester is pivaloylated in 14 hr (Stro¨mberg,
1987). In the presence of bases stronger than
pyridine (e.g., N-methylimidazole, triethyl-
amine), the P-acylation is considerably faster
(Stro¨mberg, 1987). Note, however, that even
if P-acylation occurred to some extent during
oligonucleotide synthesis, this modification
could not be easily carried through to the fully
deprotected oligonucleotide. Oligonucleotidic
chains bearing acylphosphonate modifications
will be cleaved during final deprotection upon
treatment with aqueous ammonia, and thus
only a decrease in the yield of oligomers with
the desired chain length is expected.
Reactions of protected ribonucleoside H-
phosphonate diesters with Pv-Cl are consid-
erably slower than those of deoxyribonucleo-
side derivatives (Stawinski et al., 1991b). The
presence of a bulky 2′-O-TBDMS-protecting
group vicinal to the H-phosphonate linkage
in the ribonucleoside derivatives is likely
to be one reason for the observed differ-
ence. In a typical condensation reaction (5
equiv of Pv-Cl in pyridine-acetonitrile; 1:1
v/v), only a few percent of the produced
H-phosphonate diester is pivaloylated within
22 hr (Stawinski et al., 1991b), which cor-
responds to the time required for 880 stan-
dard condensations reactions. As a rough
estimate, a 50-residue-long 2′-O-TBDMS-
oligoribonucleoside H-phosphonate synthe-
sized with 5 equiv of Pv-Cl and 50% pyridine-
acetonitrile (1:1 v/v) gives truncated sequences
(owing to P-acylation and subsequent cleav-
age) to a level of 0.1%; it is further estimated
that decreasing the excess Pv-Cl to 3 equiv in
pyridine-acetonitrile (1:3 v/v),would only pro-
duce ∼0.025% P-acylation. For oligodeoxyri-
bonucleotide synthesis, the corresponding lev-
els should be roughly 0.9% and 0.2% to 0.3%
for a coupling time of 1 min. This suggests
that P-acylation could well be responsible
for a substantial part of the observation that
DNA synthesis with H-phosphonates, in con-
tradistinction to oligoribonucleotide synthe-
sis, is not quite as efficient as with phos-
phoramidites (when using 5 equiv of Pv-
Cl in pyridine-acetonitrile, 1:1 v/v). It seems
clear that oligodeoxyribonucleotide synthesis
would benefit even more than oligoribonu-
cleotide synthesis from reducing the excess of
coupling agent and pyridine (and possibly the
basicity by using a substituted pyridine; see
below).
In the earlier discussion on preactiva-
tion, some advantages connected with us-
ing a slightly weaker base than pyridine as
a co-solvent during the condensation step
were mentioned. Such conditions are also
advantageous when considering P-acylation.
The extent of this reaction is substantially
decreased when quinoline or some substi-
tuted pyridines are used instead of pyridine
(Stawinski et al., 1991b). In the case of
deoxyribonucleoside H-phosphonate diesters,
only traces of P-acylation can be detected (31P
NMR) after 22 hr when 5 equiv of Pv-Cl in
quinoline-acetonitrile (1:3 v/v) is used. For
ribonucleoside H-phosphonate diesters, this
side reaction cannot be detected even after
22 hr under the same conditions (Stawinski
et al., 1991b).
Other potential side reactions
Notmany studies on the extent of basemod-
ification when using the H-phosphonate ap-
proach for oligonucleotide synthesis have been
reported. Error rates in oligodeoxynucleotides
that were produced using the H-phosphonate
methodology have been estimated by sequenc-
ing (Vasser et al., 1990). The average num-
ber of substitutions was found to be 1/1783
bases. These are not necessarily caused by base
modification during synthesis, but they at least
indicate the maximum level of modification
one may anticipate to be present in purified
oligomers.
Guanosine-containing dinucleoside H-
phosphonates have been reported to react with
somecondensing agents (Regberg et al., 1988).
The guanine residue reacts with Pv-Cl to
produce a modification (most likely pivaloyl-
ation of the lactam function) that is reversed
by treatment with ammonia for a much shorter
time than that used for the deprotection of
oligonucleotides. Because this reaction is also
considerably slower than the condensation,
protection of the heteroaromatic lactam sys-
tem in guanine seems to be unnecessary for
most applications when using H-phosphonate
chemistry. It may, however, be advisable
to analyze for base modifications if novel
condensing reagents are being used.
Some concern has been expressed about
the possibility of a partial loss of the 4,4′-
dimethoxytrityl group from 5′-protected
Synthesis of
Unmodified
Oligonucleotides
3.4.11
Current Protocols in Nucleic Acid Chemistry Supplement 19
H-phosphonates upon standing in vials on
automated synthesizers (Froehler et al.,
1986; Froehler and Matteucci, 1987). It
was estimated that 5′-O-(4,4′-dimethoxy-
trityl)thymidine H-phosphonate (triethy-
lammonium salt (TEAH+)) dissolved in
pyridine-acetonitrile (1:1 v/v) loses 2% of its
5′-protection within 4 weeks (Froehler and
Matteucci, 1987). Assuming a first-order
reaction, this would translate to ∼0.05%
detritylation per 1000 min. If fresh solutions
are prepared before synthesis, this can
be considered a measure of the extent to
which the loss of 5′-protection could be
for the last added nucleotide unit in the
synthesis of a 100-mer (assuming a 10-min
cycle time). The replacement of TEAH+
by 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-
a]azeponium (DBUH+) salts of nucleoside
H-phosphonate monoesters was also claimed
to decrease the amount of oligomers with
a chain length of n + 1 (Froehler and
Matteucci, 1987) owing to suppression of par-
tial detritylation during the condensation step.
It is, therefore, conceivable that the loss of the
5′-O-(4-monomethoxytrityl group) frequently
used in RNA synthesis should probably be
negligible under these conditions. Although
the detritylation step has been shown to be
completely compatible with H-phosphonate
linkages (Stawinski et al., 1988), be aware
that using acid-labile 2′-O-protecting groups
in H-phosphonate-based oligoribonucleotide
synthesis may cause problems (Rozners et al.,
1994). These can be alleviated by using the
fluoride-labile 2′-O-TBDMS or base-labile
2′-O-(2-chlorobenzoyl) groups. The former
group can be recommended for the synthesis
of longer oligoribonucleotides, whereas the
latter can be selected for shorter fragments,
owing to the simplicity and cost of preparation
of starting materials.
The oxidation step
In the phosphoramidite approach, the ox-
idation step is carried out after each cou-
pling reaction (Beaucage and Caruthers, 1981;
Matteucci and Caruthers, 1981; see also UNIT
3.3). It may be feasible to do so via the
H-phosphonate method, because the conden-
sation reaction can be accomplished in the
presence of phosphodiester functions (Fo¨ldesi
et al., 1989; Gryaznov and Potapov, 1990).
Given that H-phosphonate functions remain
intact throughout the oligomeric chain assem-
bly, the oxidation reaction can be carried out in
a single step upon completion of the synthesis.
This canbe advantageous for the preparationof
uniformly modified oligonucleotides (e.g., el-
emental sulfur can produce phosphorothioate
oligomers in one step from H-phosphonate
oligonucleotides).
The final oxidation step in the H-
phosphonate method for oligonucleotide syn-
thesis is usually performed using a solu-
tion of iodine in aqueous pyridine (Garegg
et al., 1986a,b, 1987b) or with iodine-water
in the presence of another base (triethylamine,
N-methylimidazole; Froehler and Matteucci,
1986; Froehler et al., 1986). Completeness
of the oxidation reaction is, of course, im-
portant for efficient synthesis of oligonu-
cleotides. Any oligomeric chain containing an
H-phosphonate function will be immediately
cleaved in the subsequent ammonia treatment
step (Hammond, 1962). Incomplete oxidation
will produce shorter than expected oligomers,
thus reducing the yield of the desired product.
An oxidation time of 10 min with 2% iodine
in pyridine-water (98:2) seems to be sufficient
for solid-phase synthesis of 20-mers (Garegg
et al., 1986a,b). Because the oxidation reac-
tion needs to be carried out only once after
chain assembly, one can extend the oxidation
time (rather than using stronger bases) to en-
sure complete reaction within a marginal time
loss. A longer oxidation time may still be ad-
visable for longer oligonucleotides.
Competitive hydrolysis of H-phosphonate
diesters during aqueous oxidation may be con-
sidered a potential problem. This has not yet
been reported, but it may be justified to discuss
this issue because H-phosphonate diesters are
very unstable under aqueous basic conditions
(Nyle´n, 1937; Westheimer et al., 1988). The
rate constant (kOH) for hydroxide-catalyzed
oxidation with iodine was reported to be
∼1400 to 4300 times larger than that for hy-
drolysis of a series of dialkyl H-phosphonates
(Nyle´n, 1937, 1938). These values have been
used to estimate that an aqueous pyridine
solution containing 2% iodine should give
no more than ∼5 to 25 ppm H-phosphonate
diester cleavage (Stawinski and Stro¨mberg,
1993). This suggests that hydrolysis dur-
ing oxidation is not a serious problem in
oligonucleotide synthesis according to the H-
phosphonate approach.
The rate of oxidation of nucleoside H-
phosphonate diesters with iodine-pyridine-
water can be increased by including a presilyl-
ation step (e.g., treatment with trimethylsilyl
chloride) in the synthetic protocol (Hata and
Sekine, 1974; Garegg et al., 1987b). This has,
however, been used infrequently in oligonu-
cleotide synthesis.
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Critical Parameters
The detritylation step has been shown to
be completely compatiblewithH-phosphonate
linkages (Stawinski et al., 1988). However, us-
ing acid-labile 2′-O-protecting groups in H-
phosphonate-based oligoribonucleotide syn-
thesis may cause problems (Rozners et al.,
1994). These problems can be alleviated by
using thefluoride-labile 2′-O-TBDMSor base-
labile 2′-O-2-chlorobenzoyl groups. The for-
mer group can be recommended for the syn-
thesis of longer oligoribonucleotides,while the
latter can be a choice for shorter fragments,
due to the simplicity and cost of preparing the
starting materials.
The preactivation time, i.e., contact of
a condensing agent with nucleoside 3′-H-
phosphonates before they reach the reaction
chamber, should be minimized as much as
possible, since an extended preactivation time
adversely affects rate and efficiency of inter-
nucleotide bond formation.
The amount of condensing agent and pro-
portion of pyridine in the solvent is also
important. It is convenient to use enough con-
densing agent to obtain conditions that are not
too moisture sensitive. Over a certain level,
however, excess acyl chloride increases the ex-
tent of side reactions that may lower the cou-
pling efficiency and overall yield.
The quality of the pivaloyl chloride is im-
portant for the outcome of the synthesis. Since
the reagent decomposes with time, it should
be distilled approximately once a month. The
distilled material, divided into a number of
smaller vials to avoid too frequent opening and
closing of the same bottle, can be safely stored
at −18◦ to –20◦C.
The best results are obtained if the reagent
solutions are prepared fresh just before the start
of oligonucleotide synthesis. This is most ben-
eficial for the pivaloyl chloride solution and the
oxidation solution. The latter degrades with
time (particularly when a base stronger than
pyridine is used in the oxidation solution) and
it is recommended that a fresh oxidation so-
lution be used for each synthesis. A shorter
oxidation time than that stated in the protocol
can be used for shorter oligonucleotides, but
since this is only carried out once, the time
savings are not significant and a standard time
of 30min that appears to result in complete ox-
idation (with some margin for 50- to 60-mers)
may be best.
Anticipated Results
Since 2′-protected ribonucleoside 3′-H-
phosphonates are less susceptible to double
activation with a condensing agent, and diri-
bonucleosideH-phosphonate diesters aremore
resistant to P-acylation by acyl chlorides used
as condensing agent, the H-phosphonate ap-
proach is particularly suited for the preparation
of oligoribonucleotides. Because oxidation is
carried out as a final synthetic step, the H-
phosphonate approach can also be a method of
choice for the preparation of uniformly modi-
fied oligonucleotides.
With the reported protocol, one should
be able to routinely synthesize oligoribonu-
cleotides of up to ∼50 to 60 residues with high
yield when using 5′-MMTr and 2′-O-TBDMS
protection (and N4-propionyl for cytidine, N6-
butyryl for adenosine, and N2-phenoxyacetyl
for guanosine). For oligodeoxyribonu-
cleotides, one could expect similar results.
When using 2′-O-2-chlorobenzoyl protection,
oligoribonucleotides of up to ∼20- to 30-mers
can be produced with fairly good yields.
Average coupling yields per step are usually
98% to 99+% depending on the building
blocks used.
Time Considerations
Using the protocol in this unit, the total time
for the machine-assisted part of synthesis of a
20-mer and 50-mer RNA is 4 hr 13 min and
9 hr 40 min, respectively. The total time will
depend upon protecting groups, linker to sup-
port, deprotection conditions, and purification
procedures used.
The procedure should not be stopped before
the oxidation step, because theH-phosphonate
linkages are rather labile. One can take a break
after oxidation. At that point, the oligonu-
cleotide is more stable than at the correspond-
ing stage in the phosphoramiditemethod, since
phosphodiesters are obtained after this step.
The support-bound oligonucleotide can be
stored at –20◦C until the ammonolysis step is
carried out to release the oligonucleotide from
the support and remove the N-acyl protection.
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